These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 36119104)

  • 21. Assessment of apoptotic index in various grades of oral epithelial dysplasia: A cross-sectional study.
    Pawar RB; Palaskar SJ; Kalavankar SS
    Indian J Pathol Microbiol; 2020; 63(4):534-537. PubMed ID: 33154301
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factors predicting malignant transformation in oral potentially malignant disorders among patients accrued over a 10-year period in South East England.
    Warnakulasuriya S; Kovacevic T; Madden P; Coupland VH; Sperandio M; Odell E; Møller H
    J Oral Pathol Med; 2011 Oct; 40(9):677-83. PubMed ID: 21762430
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PTEN allelic loss is an important mechanism in the late stage of development of oral leucoplakia into oral squamous cell carcinoma.
    Miyahara LAN; Pontes FSC; Burbano RMR; Conte Neto N; Guimarães DM; Fonseca FP; Pontes HAR
    Histopathology; 2018 Jan; 72(2):330-338. PubMed ID: 28858374
    [TBL] [Abstract][Full Text] [Related]  

  • 24. p53 and p16 in oral epithelial dysplasia and oral squamous cell carcinoma: A study of 208 cases.
    Cuevas Gonzalez JC; Gaitan Cepeda LA; Borges Yanez SA; Cornejo AD; Mori Estevez AD; Huerta ER
    Indian J Pathol Microbiol; 2016; 59(2):153-8. PubMed ID: 27166031
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of Diagnostic Significance of Salivary miRNA-184 and miRNA-21 in Oral Squamous Cell Carcinoma and Oral Potentially Malignant Disorders.
    Garg A; Urs AB; Koner BC; Augustine J; Guru SA
    Head Neck Pathol; 2023 Dec; 17(4):961-968. PubMed ID: 38015343
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Loss of ELF3 immunoexpression is useful for detecting oral squamous cell carcinoma but not for distinguishing between grades of epithelial dysplasia.
    AbdulMajeed AA; Dalley AJ; Farah CS
    Ann Diagn Pathol; 2013 Aug; 17(4):331-40. PubMed ID: 23643910
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of epithelial oral dysplasia in non-smokers: First steps towards precision medicine.
    Rock LD; Rosin MP; Zhang L; Chan B; Shariati B; Laronde DM
    Oral Oncol; 2018 Mar; 78():119-125. PubMed ID: 29496039
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparative analysis of langerhans cell in oral epithelial dysplasia and oral squamous cell carcinoma using antibody CD-1a.
    Upadhyay J; Rao NN; Upadhyay RB
    J Cancer Res Ther; 2012; 8(4):591-7. PubMed ID: 23361280
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PD-1/PD-L1, Treg-related proteins, and tumour-infiltrating lymphocytes are associated with the development of oral squamous cell carcinoma.
    Kujan O; Agag M; Smaga M; Vaishnaw Y; Idrees M; Shearston K; Farah CS
    Pathology; 2022 Jun; 54(4):409-416. PubMed ID: 34872754
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Malignant transformation in 5071 southern Taiwanese patients with potentially malignant oral mucosal disorders.
    Wang YY; Tail YH; Wang WC; Chen CY; Kao YH; Chen YK; Chen CH
    BMC Oral Health; 2014 Aug; 14():99. PubMed ID: 25096230
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic Changes Driving Immunosuppressive Microenvironments in Oral Premalignancy.
    Rangel R; Pickering CR; Sikora AG; Spiotto MT
    Front Immunol; 2022; 13():840923. PubMed ID: 35154165
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epidemiology and correlation of the clinicopathological features in oral epithelial dysplasia: analysis of 173 cases.
    Pereira Jdos S; Carvalho Mde V; Henriques AC; de Queiroz Camara TH; Miguel MC; Freitas Rde A
    Ann Diagn Pathol; 2011 Apr; 15(2):98-102. PubMed ID: 21190879
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lichenoid dysplasia is not a distinct pathological entity.
    Farah CS; Fox S; Shearston K; Newman L; Babic S; Vacher M
    Oral Oncol; 2021 Aug; 119():105362. PubMed ID: 34062399
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biological significance of 5-hydroxymethylcytosine in oral epithelial dysplasia and oral squamous cell carcinoma.
    Cuevas-Nunez MC; Gomes CBF; Woo SB; Ramsey MR; Chen XL; Xu S; Xu T; Zhan Q; Murphy GF; Lian CG
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2018 Jan; 125(1):59-73.e2. PubMed ID: 28743666
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development and validation of a multivariable model for prediction of malignant transformation and recurrence of oral epithelial dysplasia.
    Mahmood H; Shephard A; Hankinson P; Bradburn M; Araujo ALD; Santos-Silva AR; Lopes MA; Vargas PA; McCombe KD; Craig SG; James J; Brooks J; Nankivell P; Mehanna H; Rajpoot N; Khurram SA
    Br J Cancer; 2023 Nov; 129(10):1599-1607. PubMed ID: 37758836
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Histopathological findings of oral epithelial dysplasias and their relation to malignant transformation.
    Ellonen R; Suominen A; Kelppe J; Willberg J; Rautava J; Laine H
    Cancer Treat Res Commun; 2023; 34():100664. PubMed ID: 36481601
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prediction of malignant transformation and recurrence of oral epithelial dysplasia using architectural and cytological feature specific prognostic models.
    Mahmood H; Bradburn M; Rajpoot N; Islam NM; Kujan O; Khurram SA
    Mod Pathol; 2022 Sep; 35(9):1151-1159. PubMed ID: 35361889
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prediction of malignant transformation in oral epithelial dysplasia using infrared absorbance spectra.
    Ellis BG; Whitley CA; Triantafyllou A; Gunning PJ; Smith CI; Barrett SD; Gardner P; Shaw RJ; Weightman P; Risk JM
    PLoS One; 2022; 17(3):e0266043. PubMed ID: 35333891
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A correlation of immunohistochemical expression of
    Pandya JA; Boaz K; Natarajan S; Manaktala N; Nandita KP; Lewis AJ
    J Cancer Res Ther; 2018; 14(3):666-670. PubMed ID: 29893337
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral cancer progression and c-erbB-2/neu proto-oncogene expression.
    Hou L; Shi D; Tu SM; Zhang HZ; Hung MC; Ling D
    Cancer Lett; 1992 Aug; 65(3):215-20. PubMed ID: 1355405
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.